- Home
- DBX vs LNTH Comparison
DBX vs LNTH Comparison
Compare DBX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBX
- LNTH
- Stock Information
- Founded
- DBX 2007
- LNTH 1956
- Country
- DBX United States
- LNTH United States
- Employees
- DBX N/A
- LNTH N/A
- Industry
- DBX Computer Software: Prepackaged Software
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DBX Technology
- LNTH Health Care
- Exchange
- DBX Nasdaq
- LNTH Nasdaq
- Market Cap
- DBX 8.2B
- LNTH 7.5B
- IPO Year
- DBX 2018
- LNTH 2015
- Fundamental
- Price
- DBX $29.70
- LNTH $78.95
- Analyst Decision
- DBX Buy
- LNTH Strong Buy
- Analyst Count
- DBX 4
- LNTH 5
- Target Price
- DBX $31.00
- LNTH $133.80
- AVG Volume (30 Days)
- DBX 3.5M
- LNTH 1.3M
- Earning Date
- DBX 05-08-2025
- LNTH 05-07-2025
- Dividend Yield
- DBX N/A
- LNTH N/A
- EPS Growth
- DBX 1.18
- LNTH N/A
- EPS
- DBX 1.48
- LNTH 3.53
- Revenue
- DBX $2,541,600,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- DBX N/A
- LNTH $5.81
- Revenue Next Year
- DBX N/A
- LNTH $12.26
- P/E Ratio
- DBX $19.73
- LNTH $22.69
- Revenue Growth
- DBX 0.79
- LNTH 12.53
- 52 Week Low
- DBX $20.68
- LNTH $74.34
- 52 Week High
- DBX $33.33
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- DBX 64.88
- LNTH 27.93
- Support Level
- DBX $29.04
- LNTH $78.61
- Resistance Level
- DBX $30.40
- LNTH $83.60
- Average True Range (ATR)
- DBX 0.72
- LNTH 3.87
- MACD
- DBX 0.11
- LNTH -3.13
- Stochastic Oscillator
- DBX 76.35
- LNTH 1.12
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.